PRCT
PROCEPT BioRobotics Corporation
NASDAQ · USHealthcareMedical - Devices
$19.22+0.00%
Price as of Jul 20, 2026
PRCT valuation
PROCEPT BioRobotics Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.46x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.15x
- Price / sales
- 3.40x
- Price / cash flow
- -15.60x
Enterprise value
- Enterprise value
- $900.0M
- EV / sales
- 2.79x
- EV / EBITDA
- -9.77x
- EV / EBIT
- -8.25x
- Market cap
- $1.1B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.